Doctor profile · Federal record
Dr. Jeffrey Ainspan, M.D.
Dermatology Physician (CMS: Dermatology) · New York, NY
- NPI 1578541207
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 45 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
308A E 15Th St
New York, NY 10003
(212) 505-5790
fax (212) 505-2565 - Mailing address
-
72 Eileen Dr
Mahwah, NJ 074302806
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- May 24, 2024
- Year of graduation
- 1981 — 45 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New York #155051
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1578541207. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,557
Distinct HCPCS
10
Medicare allowed
$130,835
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 484 | 337 | $102 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 257 | 58 | $8 | |
11102 |
Biopsy of related skin growth, first growth | 159 | 129 | $111 | |
17110 |
Destruction of skin growth, 1-14 growths | 144 | 107 | $129 | |
17000 |
Destruction of precancer skin growth, 1 growth | 121 | 88 | $68 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 114 | 91 | $65 | |
17111 |
Destruction of skin growth, 15 or more growths | 50 | 29 | $156 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 47 | 24 | $1 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 39 | 39 | $129 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 36 | 34 | $142 |
In context: peer comparison
Among 139 peers in New York Dermatology Physician, average services per provider: 182. This provider delivers 8.6× the peer median.Open Payments
Industry payments received
All-time total
$855
Transactions
32
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 9 | $190.33 | |
| Ucb, INC. | 3 | $116.17 | |
| Genzyme Corporation | 3 | $106.59 | |
| Novartis Pharmaceuticals Corporation | 3 | $87.30 | |
| Lilly USA, LLC | 3 | $81.15 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $77.08 | |
| Janssen Biotech, INC. | 2 | $55.29 | |
| Incyte Corporation | 2 | $49.23 | |
| Leo Pharma INC. | 1 | $27.01 | |
| Regeneron Healthcare Solutions, INC. | 1 | $25.72 | |
| Dermavant Sciences, INC. | 1 | $22.58 | |
| Arcutis Biotherapeutics, INC. | 1 | $16.38 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
825
Patients
492
Total drug cost
$26,731
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 117 | 67 | $8,678 |
| Ketoconazole | Generic | 103 | 56 | $1,908 |
| Fluocinonide | Generic | 85 | 67 | $3,425 |
| Triamcinolone Acetonide | Generic | 69 | 47 | $553 |
| Mupirocin | Generic | 59 | 24 | $495 |
| Prednisone | Generic | 51 | 37 | $151 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 51 | 24 | $2,236 |
| Ammonium Lactate | Generic | 48 | 25 | $1,062 |
| Hydrocortisone | Generic | 44 | 32 | $391 |
| Minoxidil | Generic | 40 | 11 | $210 |
Frequently asked questions
What is Dr. Jeffrey Ainspan's medical specialty?
Dr. Jeffrey Ainspan practices Dermatology Physician in New York, NY.
Where does Dr. Jeffrey Ainspan practice?
Dr. Jeffrey Ainspan practices at 308A E 15Th St, New York, NY 10003. Office phone: 2125055790.
What is Dr. Jeffrey Ainspan's NPI?
Dr. Jeffrey Ainspan's National Provider Identifier (NPI) is 1578541207, issued by NPPES.
Does Dr. Jeffrey Ainspan accept Medicare assignment?
Yes. Dr. Jeffrey Ainspan accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jeffrey Ainspan commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.